VDAC1 and metabolic dysfunction-associated steatotic liver disease: In this study, we examined the effects of the VDAC1-derived peptide, R-Tf-D-LP4, on several parameters of a NAFLD model on a diabetic background (STZ/HFD-32) [44], with the focus on diabetes.